The weekly cardiovascular update from ACC.org Editor-in-Chief Kim Eagle, MD, MACC, covering the hottest cardiovascular topics, from new clinical guidelines to practice-changing research and innovative quality initiatives and tools.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Oct. 18)
This week’s View examines specific effects of systolic and diastolic blood pressure on various CV outcomes, the impact of hypertensive disorders of pregnancy on the onset of chronic hypertension in the first years following first pregnancy, and a look at how far we’ve come in contemporary PCI, a comparison of SYNTAX II versus SYNTAX I.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of October 11)
This week’s View focuses on hypertension treatment intensification in older adults, key points on physical activity and exercise in patients with spontaneous coronary artery dissection and fibromuscular dysplasia, and CV disease risk among cigarette smokers who transitioned to vaping.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Oct. 4)
This week’s View focuses on prevention: the association of statin therapy initiation and diabetes progression, the relationship between target BP and outcomes in patients with left ventricular hypertrophy, and the effects of lifestyle modifications in patients with resistant hypertension.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of September 27)
This week’s View focuses on the effect of neprilysin inhibition on BP in patients with HFpEF and resistant hypertension, three- vs. two-drug therapy for patients with newly diagnosed pulmonary artery hypertension, and early invasive angiography in acute HF.
Eagle's Eye View: Your Weekly CV Update From ACC.org (Week of September 20)
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of September 13)
This week’s View summarizes articles about whether there are differences in daily symptom scores on statin, placebo, and no treatment in participants who had abandoned statins; the safety and immunogenicity of heterologous schedules with different coronavirus disease 2019 (COVID-19) vaccines; and the effectiveness of inhaled budesonide in reducing recovery time and rates of COVID-19-related hospital admission or death in people at high risk of an adverse outcome.